These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 17475663

  • 1. VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.
    Amura CR, Brodsky KS, Groff R, Gattone VH, Voelkel NF, Doctor RB.
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C419-28. PubMed ID: 17475663
    [Abstract] [Full Text] [Related]

  • 2. CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.
    Amura CR, Brodsky KS, Gitomer B, McFann K, Lazennec G, Nichols MT, Jani A, Schrier RW, Doctor RB.
    Am J Physiol Cell Physiol; 2008 Mar; 294(3):C786-96. PubMed ID: 18199703
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.
    Masyuk TV, Radtke BN, Stroope AJ, Banales JM, Masyuk AI, Gradilone SA, Gajdos GB, Chandok N, Bakeberg JL, Ward CJ, Ritman EL, Kiyokawa H, LaRusso NF.
    Gastroenterology; 2012 Mar; 142(3):622-633.e4. PubMed ID: 22155366
    [Abstract] [Full Text] [Related]

  • 8. Nonselective Cyclooxygenase Inhibition Retards Cyst Progression in a Murine Model of Autosomal Dominant Polycystic Kidney Disease.
    Zhang M, Srichai MB, Zhao M, Chen J, Davis LS, Wu G, Breyer MD, Hao CM.
    Int J Med Sci; 2019 Mar; 16(1):180-188. PubMed ID: 30662341
    [Abstract] [Full Text] [Related]

  • 9. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid.
    Nichols MT, Gidey E, Matzakos T, Dahl R, Stiegmann G, Shah RJ, Grantham JJ, Fitz JG, Doctor RB.
    Hepatology; 2004 Oct; 40(4):836-46. PubMed ID: 15382115
    [Abstract] [Full Text] [Related]

  • 10. Identifying cystogenic paracrine signaling molecules in cyst fluid of patients with polycystic kidney disease.
    Kenter AT, van Rossum-Fikkert SE, Salih M, Verhagen PCMS, van Leenders GJLH, Demmers JAA, Jansen G, Gribnau J, Zietse R, Hoorn EJ.
    Am J Physiol Renal Physiol; 2019 Jan 01; 316(1):F204-F213. PubMed ID: 30403162
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases.
    Fabris L, Cadamuro M, Fiorotto R, Roskams T, Spirlì C, Melero S, Sonzogni A, Joplin RE, Okolicsanyi L, Strazzabosco M.
    Hepatology; 2006 May 01; 43(5):1001-12. PubMed ID: 16628643
    [Abstract] [Full Text] [Related]

  • 13. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
    Chang MY, Parker E, Ibrahim S, Shortland JR, Nahas ME, Haylor JL, Ong AC.
    Nephrol Dial Transplant; 2006 Aug 01; 21(8):2078-84. PubMed ID: 16720597
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.
    Park EY, Sung YH, Yang MH, Noh JY, Park SY, Lee TY, Yook YJ, Yoo KH, Roh KJ, Kim I, Hwang YH, Oh GT, Seong JK, Ahn C, Lee HW, Park JH.
    J Biol Chem; 2009 Mar 13; 284(11):7214-22. PubMed ID: 19098310
    [Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase 2 inhibition slows disease progression and improves the altered renal lipid mediator profile in the Pkd2WS25/- mouse model of autosomal dominant polycystic kidney disease.
    Monirujjaman M, Aukema HM.
    J Nephrol; 2019 Jun 13; 32(3):401-409. PubMed ID: 30671914
    [Abstract] [Full Text] [Related]

  • 17. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y, Inagi R, Yoshihara D, Kugita M, Nagao S, Shimizu A, Takeda N, Wake M, Honda K, Zhou J, Nangaku M.
    Mol Cell Biol; 2017 Dec 15; 37(24):. PubMed ID: 28993480
    [Abstract] [Full Text] [Related]

  • 18. Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin.
    Kim I, Ding T, Fu Y, Li C, Cui L, Li A, Lian P, Liang D, Wang DW, Guo C, Ma J, Zhao P, Coffey RJ, Zhan Q, Wu G.
    J Am Soc Nephrol; 2009 Dec 15; 20(12):2556-69. PubMed ID: 19939939
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway.
    Xu T, Wang NS, Fu LL, Ye CY, Yu SQ, Mei CL.
    Mol Biol Rep; 2012 Jul 15; 39(7):7743-53. PubMed ID: 22415852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.